Erasca share price today

(ERAS)

Erasca share price is $2.57 & ₹218.96 as on 25 Dec 2024, 2.30 'hrs' IST

$2.57

▲

0.09

(3.63%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Erasca share price in Dollar and Rupees. Guide to invest in Erasca from India. Also see the sentimental analysis on Indian investors investing in Erasca. Get details on the Indian mutual funds that are investing in Erasca. Get Analyst recommendations and forecasts along with all the Erasca's financials.

Erasca share price movements

Today's Low: $2.45
Today's High: $2.60
$2.57
4.67%
Downside
Day's Volatility :5.77%
Upside
1.15%
52 Weeks Low: $1.64
52 Weeks High: $3.45
$2.57
36.19%
Downside
52 Weeks Volatility :52.46%
Upside
25.51%

Erasca Returns

Period	Erasca Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-5.17%	-9.0%	0.0%
6 Months	11.26%	-4.6%	0.0%
1 Year	19.53%	3.0%	0.0%
3 Years	-81.91%	0.0%	-21.1%

Erasca Key Statistics

in dollars & INR

Previous Close	$2.48
Open	$2.49
Today's High	$2.6
Today's Low	$2.45
Market Capitalization	$726.6M
Today's Volume	$1.0M
52 Week High	$3.45
52 Week Low	$1.64
Revenue TTM	$0.0
EBITDA	$-150.9M
Earnings Per Share (EPS)	$-0.79
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-38.9%

How to invest in Erasca from India?

It is very easy for Indian residents to invest directly in Erasca from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Erasca stock in both Indian Rupees (INR) and US Dollars (USD). Search for Erasca or ERAS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Erasca or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Erasca shares which would translate to 0.332 fractional shares of Erasca as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Erasca, in just a few clicks!

Returns in Erasca for Indian investors in Rupees

Investment Value

₹1,00,000

Erasca investment value today

Current value as on today

₹1,21,774

Returns

₹21,774

(+21.77%)

Returns from Erasca Stock

₹19,535 (+19.53%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Erasca

40%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Erasca on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 40% more investors are searching Erasca in the last 30 days versus the previous period.

Global Institutional Holdings in Erasca

T. Rowe Price Investment Management,Inc.
5.95%
VR Adviser, LLC
5.74%
Suvretta Capital Management, LLC
4.87%
Vanguard Group Inc
4.70%
ARCH VENTURE CORP
3.91%
Logos Global Management LP
3.86%

Analyst Recommendation on Erasca

Buy

85%Buy

14%Hold

0%Sell

Based on 14 Wall street analysts offering stock ratings for Erasca(by analysts ranked 0 to 5 stars)

Based on 14 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Erasca

What analysts predicted

Upside of 94.55%

Current:

$2.57

Target:

$5.00

Insights on Erasca

Price Movement
In the last 7 days, ERAS stock has moved up by 4.9%
ERAS vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 8.8%
ERAS vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 107.5%

Erasca Technicals Summary

Sell

Neutral

Buy

Erasca is currently in a neutral trading position according to technical analysis indicators.

Erasca Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Erasca Inc.	-7.55%	11.26%	19.53%	-81.91%	-85.26%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-3.72%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Erasca Inc.	NA	NA	NA	-0.75	-0.39	-0.19	NA	1.65
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Erasca Inc.	Buy	$726.6M	-85.26%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Erasca

our mission at erasca is embedded in our name: to erase cancer in patients by creating a new generation of oncology drugs that we hope will not just treat, but actually cure. energized by recent scientific discoveries and advances in drugging various biological drivers of cancer, we are committed to solving oncology’s hardest problems. we have assembled a proven team and joined forces with world-class collaborators who embrace our ambitious goals.

Organization	Erasca
Employees	126
CEO	Dr. Jonathan E. Lim M.D.
Industry	Services

Management People of Erasca

Name	Title
Dr. Jonathan E. Lim M.D.	Co-Founder, Chairman & CEO
Dr. David M. Chacko M.D.	CFO & Chief Business Officer
Mr. Ebun S. Garner Esq., J.D.	General Counsel & Corporate Secretary
Dr. Michael D. Varney Ph.D.	Chairman of Research & Development, Scientific Advisory Board Member and Director
Dr. Nik Chetwyn Ph.D.	Chief Operating Officer
Dr. Lisa Tesvich-Bonora Ph.D.	Chief People Officer
Mr. Brian L. Baker CPA, M.S.	Senior Vice President of Finance
Ms. Chandra D. Lovejoy M.S.	Chief Regulatory Affairs Officer
Dr. Robert Shoemaker Ph.D.	Senior Vice President of Research
Dr. Shannon R. Morris M.D., Ph.D.	Chief Medical Officer

Important FAQs about investing in Erasca from India :

What is Erasca share price today?

Erasca share price today stands at $2.57, Open: $2.49 ; Previous Close: $2.48 ; High: $2.60 ; Low: $2.45 ; 52 Week High: $3.45 ; 52 Week Low: $1.64. The stock opens at $2.49, after a previous close of $2.48. The stock reached a daily high of $2.60 and a low of $2.45, with a 52-week high of $3.45 and a 52-week low of $1.64.

Can Indians buy Erasca shares?

Yes, Indians can invest in the Erasca (ERAS) from India.

With INDmoney, you can buy Erasca at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Erasca at zero transaction cost.

How can I buy Erasca shares from India?

It is very easy to buy Erasca from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Erasca be purchased?

Yes, you can buy fractional shares of Erasca with INDmoney app.

What are the documents required to start investing in Erasca stocks?

To start investing in Erasca, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.